Physician profile
Hardikkumar M Patel
NPI 1790165736
$6,728.34
in general payments reported to CMS, 2019-2025
27 companies · $1,510 in 2025
The $1,510 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $55.70 · 2022: $674 · 2023: $1,760 · 2024: $2,728 · 2025: $1,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,840 · Grant: $1,126 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,839.77 |
| Grant | $1,126.44 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,390.06 | 2022-2024 | Watchman Access System |
| Novartis Pharmaceuticals Corporation | $748.89 | 2023-2025 | |
| Shockwave Medical, INC | $701.72 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $486.24 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $485.49 | 2022-2025 | Lifevest |
| Abbott Laboratories | $437.66 | 2020-2023 | Amplatzer, Diamondback Coronary |
| Abiomed | $378.91 | 2022-2025 | Impella |
| Pfizer INC. | $373.35 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.83 | 2024-2025 | Jardiance |
| Medtronic, INC. | $261.32 | 2022-2023 | Onyx Frontier |
| Kiniksa Pharmaceuticals International, Plc | $228.23 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $172.42 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $157.32 | 2024 | Xarelto |
| Novo Nordisk INC | $96.65 | 2023-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $86.34 | 2024 | Verquvo |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $81.83 | 2024 | Zio Monitor, Zio Xt Patch |
| Kiniksa Pharmaceuticals, LTD. | $68.00 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $61.57 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $58.08 | 2024-2025 | Brilinta, Farxiga |
| Alnylam Pharmaceuticals INC. | $41.62 | 2024-2025 | Onpattro, Amvuttra |
| Lantheus Medical Imaging, INC. | $24.35 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $23.92 | 2024 | Eliquis |
| Heartflow, INC. | $22.16 | 2025 | |
| Asahi Intecc USA, INC. | $20.25 | 2024 | Peripheral Vascular |
| Kestra Medical Technology Services, INC. | $19.92 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $18.38 | 2024 | Kengreal |
| Edwards Lifesciences Corporation | $17.83 | 2024 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hardikkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.